Skip to main contentSkip to navigation
Sirius Investors
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCO
NYSEHealthcare

Revenue Analysis - BLCO

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

BLCO Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Device Products

0.0% of total revenue

$480.0M

Over the Counter Products

0.0% of total revenue

$444.0M

Pharmaceutical Products

0.0% of total revenue

$266.0M

Branded and Other Generic Products

0.0% of total revenue

$49.0M

Other Revenues

0.0% of total revenue

$5.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Branded and Other Generic Products
Device Products
Other Revenues
Over the Counter Products
Pharmaceutical Products
3/31/2026$49.0M$480.0M$5.0M$444.0M$266.0M
12/31/2025$72.0M$518.0M$7.0M$489.0M$319.0M
9/30/2025$59.0M$484.0M$4.0M$454.0M$280.0M
6/30/2025$58.0M$472.0M$6.0M$482.0M$260.0M
3/31/2025$54.0M$448.0M$4.0M$409.0M$222.0M
12/31/2024$69.0M$476.0M$5.0M$462.0M$268.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Branded and Other Generic Products-31.9%
Other Revenues-28.6%
Pharmaceutical Products-16.6%

Geographic Regions

Growing Regions
Other Countries+40.2%
SPAIN+30.0%
JAPAN+11.1%
Declining Regions
GERMANY-15.8%
POLAND-11.8%

Earnings Reports

Want to see how BLCO's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports